Filter & sort
The latest funding rounds from the UK tech ecosystem. Updated 14 September 2026.
Announcements
2,177
Total raised
£9.5B
disclosed amounts
This month
£14.4M
raised so far
The funding round was backed by GC Angels and Deepbridge Capital to fast track the consumer launch of the platform.
"Consumers are increasingly aware of the advantages of using digital investment managers as a simple, low cost way to invest money, whether that’s to save for a specific future goal such as a house purchase or for retirement, or just to build a rainy day pot."
The funding round was led by angel investor Ashley Cooper with participation from Angels Invest Wales and Hambro Perks Insurtech Gateway.
"David and his co-founders make an impressive team who have developed a massively scalable, market leading technology that addresses a real need in a huge growth sector. Our investment syndicate is excited to be backing DAS and I am delighted to have led this funding round accessing the Wales Angel Co-investment Fund."
The funding was led by the Development Bank of Wales to support the commercial launch of the Podium device.
"Detecting diabetic foot complications as early as possible is crucial as people with diabetes could suffer from a loss of feeling in their feet, which can lead to foot ulcers which increases the risk of amputation. Once a patient has received an amputation, their quality of life is impacted. More worryingly, life expectancy is 5 years post-amputation, on average."
A group of eight NorthInvest angels has backed the medical technology developer.
"Current treatments for these conditions require frequent hospitalisations for intravenous treatment with high doses of diuretics which is not only inconvenient for patients and associated with a risk of kidney injury but also costly. We offer a gentler, safer solution that can be delivered at home, offering patients better quality of life and reducing hospital admissions and costs to healthcare providers. This round of funding enables Renephra to carry out pilot clinical studies to demonstrate a viable success rate in target patients and to understand factors related to success. This is an essential next step for the company in advancing this much needed and promising technology through to regulatory approvals and making it available to clinicians and patients."
Foresight Group provided the capital through the Midlands Engine Investment Fund to support product prototyping and intellectual property development.
"This innovative game-changing textile manufacturing technology developed by Footfalls & Heartbeats is precisely the type of opportunity MEIF was created for, where funding from other sources is hard to come by. We look forward to seeing the Company develop and grow as we share the journey with this enthusiastic team."
